You are here: Industry Insights > Market News > WHO cautions against to ‘vaccine nationalism’

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

WHO cautions against to ‘vaccine nationalism’

expresspharmaAugust 20, 2020

Tag: WHO , Vaccine , coronavirus

Favorites

Countries putting their own interests ahead of others in trying to ensure supplies of a possible coronavirus vaccine are making the pandemic worse, said World Health Organization chief Tedros Adhanom Ghebreyesus.

“(Acting) strategically and globally is actually in each country’s national interest – no one is safe until everyone is safe,” he told a virtual briefing calling for an end to “vaccine nationalism”.

He said he had sent a letter to all WHO members asking them to join the multilateral COVAX vaccine effort.

Previous:A Comparison of Top Ten Best-Selling Oncology Drugs in China and the U.S. in 2019

Next:Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

WHO cautions against to ‘vaccine nationalism’ | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Hualan inactivated flu vaccine

Hot Selling Wholesale Cosmetic Grade Herbal Extract Salicin White Willow Bark Extract Powder

DTaP-Hib combined Vaccine

Hualan bio H7N9 Inactivated Influenza Vaccine by Hualan Bio

2019-nCoV Vaccine(Vero Cells),Inactivated

Hualan Biological Recombinant Hepatitis B Vaccine (Hansenula polymorpha)

Wholesale Mastic Gum Serrata Frankincense Glucosamine Resin Boswellia Extract

Haemophilus Influenza Type B Conjugate Vaccine

Factory Bp/USP/FCC Sugar Substitute Xylitol Wholesale Price

Wholesale Hot Selling pear powder

WHO cautions against to ‘vaccine nationalism’

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>